Podcast: Full Time jobs growth for the year to March 2019 was 3.0% By Michael Knox 24 April 2019, 12:44 PM This is more than twice the average growth rate of full time employment since January 2008. Read more...
Why the Australian cash rate will not fall By Michael Knox 23 April 2019, 11:30 AM Rising export commodity prices will beat out falling house prices and make the economy stronger than expected. Read more...
Technical Analysis: 23 April 2019 By Violeta Todorova 23 April 2019, 9:36 AM Webjet, Volpara, QBE Insurance Group, Class and Nanosonics Read more...
Banks: Enough positives not priced in By Azib Khan 17 April 2019, 1:03 PM We generally expect mid-single-digit underlying EPS growth over the next 3 years. Read more...
Technical Analysis: 15 April 2019 By Violeta Todorova 15 April 2019, 10:01 AM Telstra Corporation, Megaport, Commonwealth Bank, ANZ Banking Group and Westpac Banking Group Read more...
Whitehaven Coal: Poised for a return of the momentum investor By Tom Sartor 15 April 2019, 8:00 AM We think the market is discounting pricing risk excessively, and that now is a smart time to accumulate. Read more...
Technical Analysis: 12 April 2019 By Violeta Todorova 12 April 2019, 11:03 AM DuluxGroup, Coles Group, Select Harvests and Spark Infrastructure Read more...
Results Road Map: 24 August 2020 By Andrew Tang 24 August 2020, 12:00 AM We are happy to buy the following stocks: Coca-Cola Amatil, Santos, Beacon Lighting, Pro Medicus, InvoCare, Waypoint REIT, The Start Entertainment Group and Perpetual Limited Read more...
An Update on COVID-19 Vaccine Development By Raymond Chan 24 April 2020, 12:00 AM 新冠肺炎疫苗真可快將面世？ 世界各地法寶盡出，奮力對抗新型冠狀病毒肺炎這個共同「敵人」，可惜迄今為止只能拖慢疫情擴散的速度，顯得治標不治本。其實，大家都明白到，若要成功戰勝新冠肺炎，唯一最有效的方法就是成功研發出疫苗。 很大程度上要感謝中國，在疫情初期就分享了新冠肺炎病毒的基因排序，目前已經有至少60種候選新冠肺炎疫苗，正在經由多間藥廠、生物科技公司和研究機構進行試驗 抗疫最強「武器」 臨床試驗階段 目前為止，美國生物科技公司 Moderna Therapeutics 所研發的疫苗 mRNA-1273，是最讓各方人士期盼的抗疫最強「武器」。此疫苗已經在美國華盛頓州進行臨床試驗，用於此次疫情中的高危群體，例如是前線醫護人員 澳洲的科研人員也不甘後人，現正加快進行大規模的人體測試，觀察過去幾十年以來一直用於治療肺結核病的現成疫苗，能否有效地保護前線醫護人員免受新冠肺炎感染。臨床測試中的新冠肺炎疫苗 Bacillus Calmette-Guerin（簡稱BCG），將會用於分布在澳洲全國各地的4,000位醫院前線醫護人員，務求從中了解此疫苗能否有效地紓緩新冠肺炎的病徵 BCG疫苗原本是用於對付... Read more...
Zip Co: AGM and capital raising By Richard Coles 03 December 2019, 12:00 AM Zip Co (ASX:Z1P) has announced a A$60m capital raising in conjunction with its AGM. While we are supportive of Z1P's growth plans, the current capital raising does add to significant dilution throughout CY19 which needs to be justified by execution. Read more...